MERTK and leukemia: Studies have demonstrated that these compounds inhibit MERTK phosphorylation and have a variety of functional effects in in vitro cell-based assays and in vivo models of solid tumors and/or leukemia [51,52,65,80,81,82,83,84,85,86,102,103].